Cardiovascular pharmacogenetics of anti-thrombotic agents and non-steroidal anti-inflammatory drugs.

Abstract excerpt

The use of antithrombotic agents, particularly antiplatelet drugs like aspirin and clopidogrel, has been instrumental in decreasing the risk for adverse cardiovascular events across a wide range of patients. However, despite the established benefits, the use of these medications remains suboptimal. There is a high degree of inter-individual variation in response to these treatments, whereby patients experience...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Anti-Inflammatory Agents, Non-Steroidal
• Share to Cardiovascular Diseases